Cubist Systematic Strategies’s Strongbridge Biopharma plc. SBBP Stock Holding History

Cubist Systematic Strategies’s Portfolio SBBP Stock Details SBBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-48,481	Closed	-$134K	–	3213
2021 Q1	$134K	Buy	+48,481	New	+$146K	﹤0.01%	2590
2019 Q4	–	Sell	-928	Closed	-$2K	–	2616
2019 Q3	$2K	Buy	+928	New	+$2.49K	﹤0.01%	2173
2018 Q4	–	Sell	-18,986	Closed	-$92K	–	2363
2018 Q3	$92K	Sell	18,986 -2,601	-12%	-$13.3K	0.01%	1618
2018 Q2	$130K	Buy	+21,587	New	+$158K	0.01%	1467

Other funds holding SBBP

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

Cubist Systematic Strategies's SBBP Position: Q2 2021 in Review

Cubist Systematic Strategies sold out of Strongbridge Biopharma plc. (SBBP) in Q2 2021, closing a stake of 48,481 shares — an estimated $134K sold.

Cubist Systematic Strategies first reported a position in SBBP in Q2 2018 and held it in 4 quarters. The position peaked at $134K in Q1 2021. 59 funds tracked by Wall St. Rank hold SBBP as of Q2 2021.

Cubist Systematic Strategies reported no remaining Strongbridge Biopharma plc. position as of Q2 2021 after selling out during the quarter.
Cubist Systematic Strategies sold 48,481 Strongbridge Biopharma plc. shares in Q2 2021, an estimated $134K.
Cubist Systematic Strategies first reported a position in Strongbridge Biopharma plc. in Q2 2018 and held it in 4 quarters.
Cubist Systematic Strategies's Strongbridge Biopharma plc. position peaked at $134K in Q1 2021.
59 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q2 2021.

Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.